|Articles|July 22, 2019

Study: Femtosecond laser-assisted arcuate incisions and plate-haptic toric IOLs

ICYMI: Frank W. Bowden, III, MD, FACS shares the take-home message from his 2019 ASCRS presentation. Check it out below!

Frank W. Bowden, III, MD, FACS shares the take-home message from the presentation he delivered at the 2019 meeting of the American Society of Cataract and Refractive Surgery: "Improved Outcomes with Femtosecond Laser-Assisted Arcuate Incisions and Plate-Haptic Toric IOLs to Correct Presbyopia and Astigmatism."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe

Study: Femtosecond laser-assisted arcuate incisions and plate-haptic toric IOLs

Related Content

Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities

IOLs: What Every Surgeon Needs to Know | Ep. 2: Enhanced monofocal IOLs

TECNIS PureSee IOL launches in US following FDA approval for cataract surgery

Positive Topline Results, Promising Future for Bimatoprost Drug Pad-IOL System, With Fiaz Zaman, MD

Modular, Shape-Changing IOL for Presbyopia Improves Vision at 36 Months, Demonstrates Lasting Effects

Latest CME

PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence

PER Global Perspectives: Differentiating and Managing Toxicities with TROP2-Targeted ADCs in NSCLC Through Multidisciplinary Pathways

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Interventional Dry Eye: A Stepwise Treatment & Management Approach

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

Trending on Eye Care Network - Ophthalmology Times

Emerging dry eye therapies and co-managing MGD: Ping Moore, OD

Why aren’t there enough ophthalmologists?